Diferencia entre revisiones de «Levofloxacin»
(Text replacement - "==Source== <references/>" to "==References== <references/>") |
(Text replacement - "0 mg" to "0mg") |
||
| Línea 10: | Línea 10: | ||
===[[Pneumonia]]=== | ===[[Pneumonia]]=== | ||
*Community acquired | *Community acquired | ||
** | **750mg PO/IV q24h x 5 days | ||
*Nosocomial | *Nosocomial | ||
**750 gm PO/IV q24h x 7-14 days | **750 gm PO/IV q24h x 7-14 days | ||
| Línea 18: | Línea 18: | ||
===[[Pyelonephritis]]=== | ===[[Pyelonephritis]]=== | ||
* | *750mg PO/IV q24h x 5 days | ||
===[[Skin infection]]=== | ===[[Skin infection]]=== | ||
*Uncomplicated | *Uncomplicated | ||
** | **500mg PO/IV q24h x 7-10 days | ||
*Complicated | *Complicated | ||
** | **750mg PO/IV q24h x 7-14 days | ||
===[[UTI]]=== | ===[[UTI]]=== | ||
*Uncomplicated | *Uncomplicated | ||
** | **250mg PO/IV q24h x 3days | ||
*Complicated | *Complicated | ||
** | **750mg PO/IV q24h x 5 days | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===[[Pneumonia]] (Community acquired)=== | ===[[Pneumonia]] (Community acquired)=== | ||
*6 months - 4 years old | *6 months - 4 years old | ||
**16- | **16-20mg/kg/day IV or PO, divided q12h x 10 days | ||
*5-16 years old | *5-16 years old | ||
**8- | **8-10mg/kg/day IV or PO, divided q12h x 10 days | ||
==Special Populations== | ==Special Populations== | ||
Revisión del 03:54 20 jul 2016
General
- Type: Fluoroquinolone
- Dosage Forms:
- PO
- IV
- Inhalational
- Common Trade Names: Levaquin
Adult Dosing
Pneumonia
- Community acquired
- 750mg PO/IV q24h x 5 days
- Nosocomial
- 750 gm PO/IV q24h x 7-14 days
Prostatitis
- 500 MG PO/IV q24h x 28 days
Pyelonephritis
- 750mg PO/IV q24h x 5 days
Skin infection
- Uncomplicated
- 500mg PO/IV q24h x 7-10 days
- Complicated
- 750mg PO/IV q24h x 7-14 days
UTI
- Uncomplicated
- 250mg PO/IV q24h x 3days
- Complicated
- 750mg PO/IV q24h x 5 days
Pediatric Dosing
Pneumonia (Community acquired)
- 6 months - 4 years old
- 16-20mg/kg/day IV or PO, divided q12h x 10 days
- 5-16 years old
- 8-10mg/kg/day IV or PO, divided q12h x 10 days
Special Populations
- Pregnancy Rating: C
- Lactation: Probably Safe
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- Myasthenia gravis
- Long QT
- Uncorrected electrolyte abnormalities
Adverse Reactions
Serious
- Anaphylaxis
- Hypersensitivity
- Phototoxicity
- C. difficile diarrhea
- Seizures
- Depression / Suicidal ideation
- Torsades de Pointes
- Vasculitis
- Renal toxicity
- Hepatic toxicity
Common
Pharmacology
- Half-life: 6-8 h
- Metabolism: CYP450
- Excretion: Urine
- Mechanism of Action: Bactericidal, inhibits DNA gyrase / Topoisomerase IV
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014